A bioengineered retinal pigment epithelial monolayer for advanced, dry age-related macular degeneration

Author:

Kashani Amir H.1ORCID,Lebkowski Jane S.2,Rahhal Firas M.3,Avery Robert L.4,Salehi-Had Hani5ORCID,Dang Wei6,Lin Chih-Min6ORCID,Mitra Debbie1ORCID,Zhu Danhong7,Thomas Biju B.1,Hikita Sherry T.8,Pennington Britney O.8,Johnson Lincoln V.28,Clegg Dennis O.8ORCID,Hinton David R.17,Humayun Mark S.19ORCID

Affiliation:

1. University of Southern California (USC) Roski Eye Institute, USC Institute for Biomedical Therapeutics, and Department of Ophthalmology, Keck School of Medicine, USC, 1450 San Pablo, Los Angeles, CA 90033, USA.

2. Regenerative Patch Technologies, 150 Gabarda Way, Portola Valley, CA 94028–7445, USA.

3. Retina Vitreous Associates Medical Group, 9001 Wilshire Boulevard, Suite 301, Beverly Hills, CA 90211, USA.

4. California Retina Consultants, 525 East Micheltorena Street, Santa Barbara, CA 93103, USA.

5. Atlantis Eyecare, 7777 Edinger Avenue, Suite 234, Huntington Beach, CA 92647, USA.

6. Center for Biomedicine and Genetics, Beckman Research Institute of City of Hope, 1500 East Duarte Road, Duarte, CA 91010, USA.

7. Department of Pathology, Keck School of Medicine, USC, 1441 Eastlake Avenue, NRT 7503, Los Angeles, CA 90033, USA.

8. Center for Stem Cell Biology and Engineering, Neuroscience Research Institute, Mail Code 5060, University of California, Santa Barbara, CA 93016, USA.

9. Department of Biomedical Engineering, 1042 Downey Way, Denney Research Center (DRB) 140, USC, Los Angeles, CA 90089–1111, USA.

Abstract

Implantation of a human embryonic stem cell–derived retinal pigment epithelial monolayer is feasible in human subjects with advanced, dry age-related macular degeneration.

Funder

California Institute for Regenerative Medicine

Regenerative Patch Technologies LLC

Lori Mars Foundation

William K Bowes Foundation

The Vermont Community Foundation

The Breaux Foundation

The Wilcox Family Foundation

Publisher

American Association for the Advancement of Science (AAAS)

Subject

General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3